The results showed that β1 integrin, which had been immunoprecipitated from endometrial cancer tissues, certainly contained β1–6 GlcNAc branching (Figure 1C), suggesting that β1 integrin is a target substrate of GnT-V in endometrial cancers. This evidence concerns the gene MGAT5 and endometrial cancer.